96 related articles for article (PubMed ID: 21689684)
1. p-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission.
Onogi H; Nakagawasai O; Sato A; Mitazaki S; Nakaya K; Watanabe K; Niijima-Yaoita F; Tan-No K; Arai Y; Kikuchi T; Tadano T
Behav Brain Res; 2011 Oct; 224(1):159-65. PubMed ID: 21689684
[TBL] [Abstract][Full Text] [Related]
2. p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission.
Onogi H; Nakagawasai O; Tan-No K; Mitazaki S; Sato A; Nakaya K; Niijima F; Arai Y; Kikuchi T; Tadano T
Behav Brain Res; 2010 Dec; 214(2):349-56. PubMed ID: 20540968
[TBL] [Abstract][Full Text] [Related]
3. [Central Administration of p-Hydroxyamphetamine Produces a Behavioral Stimulant Effect in Rodents: Contribution of Dopamine and Serotonin Neurotransmission].
Onogi H
Yakugaku Zasshi; 2023; 143(11):883-887. PubMed ID: 37914334
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors.
Nakaya K; Nakagawasai O; Arai Y; Onogi H; Sato A; Niijima F; Tan-No K; Tadano T
Behav Brain Res; 2011 Mar; 218(1):165-73. PubMed ID: 21130810
[TBL] [Abstract][Full Text] [Related]
5. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine.
Fletcher PJ; Selhi ZF; Azampanah A; Sills TL
Neuropsychopharmacology; 2001 Apr; 24(4):399-409. PubMed ID: 11182535
[TBL] [Abstract][Full Text] [Related]
6. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
[TBL] [Abstract][Full Text] [Related]
7. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.
Liechti ME; Geyer MA; Hell D; Vollenweider FX
Neuropsychopharmacology; 2001 Mar; 24(3):240-52. PubMed ID: 11166515
[TBL] [Abstract][Full Text] [Related]
8. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.
Jennings KA; Sheward WJ; Harmar AJ; Sharp T
Neuropharmacology; 2008 Apr; 54(5):776-83. PubMed ID: 18241894
[TBL] [Abstract][Full Text] [Related]
9. Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition.
Kusljic S; Copolov DL; van den Buuse M
Neuropsychopharmacology; 2003 Dec; 28(12):2138-47. PubMed ID: 12888784
[TBL] [Abstract][Full Text] [Related]
10. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats.
Yamada S; Harano M; Annoh N; Nakamura K; Tanaka M
Biol Psychiatry; 1999 Sep; 46(6):832-8. PubMed ID: 10494453
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus.
Adams W; van den Buuse M
Neuropharmacology; 2011 Sep; 61(3):458-67. PubMed ID: 21477601
[TBL] [Abstract][Full Text] [Related]
12. The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats.
Sutherland JE; Page ME; Conti LH
Pharmacol Biochem Behav; 2008 May; 89(3):324-37. PubMed ID: 18280562
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine.
Arai Y; Kim SK; Kinemuchi H; Tadano T; Satoh SE; Satoh N; Kisara K
J Neurochem; 1990 Aug; 55(2):403-8. PubMed ID: 2370545
[TBL] [Abstract][Full Text] [Related]
14. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.
Barr AM; Lehmann-Masten V; Paulus M; Gainetdinov RR; Caron MG; Geyer MA
Neuropsychopharmacology; 2004 Feb; 29(2):221-8. PubMed ID: 14603268
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.
Steed E; Jones CA; McCreary AC
Behav Brain Res; 2011 Jun; 220(1):9-19. PubMed ID: 21262272
[TBL] [Abstract][Full Text] [Related]
16. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Varty GB; Bakshi VP; Geyer MA
Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
[TBL] [Abstract][Full Text] [Related]
18. PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.
Larrauri JA; Levin ED
Psychopharmacology (Berl); 2010 Dec; 212(4):551-8. PubMed ID: 20811878
[TBL] [Abstract][Full Text] [Related]
19. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
Gogos A; Kwek P; Chavez C; van den Buuse M
J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
[TBL] [Abstract][Full Text] [Related]
20. 8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment.
Czyrak A; Maćkowiak M; Chocyk A; Fijał K; Gadek-Michalska A; Wedzony K
Neuropsychopharmacology; 2003 Jul; 28(7):1300-10. PubMed ID: 12700680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
